91 related articles for article (PubMed ID: 38302841)
1. Interaction between microbiota and immunity and its implication in colorectal cancer.
Xing C; Du Y; Duan T; Nim K; Chu J; Wang HY; Wang RF
Front Immunol; 2022; 13():963819. PubMed ID: 35967333
[TBL] [Abstract][Full Text] [Related]
2. Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer.
Okuda S; Shimada Y; Tajima Y; Yuza K; Hirose Y; Ichikawa H; Nagahashi M; Sakata J; Ling Y; Miura N; Sugai M; Watanabe Y; Takeuchi S; Wakai T
Comput Struct Biotechnol J; 2021; 19():3330-3338. PubMed ID: 34188781
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Colorectal Cancer After Intestinal Infection Due to
Patel RK; Cardeiro M; Frankel L; Kim E; Takabe K; Rashid OM
World J Oncol; 2024 Apr; 15(2):279-286. PubMed ID: 38545472
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived metabolites in CRC progression and causation.
Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
[TBL] [Abstract][Full Text] [Related]
5. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the gut microbiota and their metabolites in human intestinal epithelial cells of patients with colorectal cancer.
Jahani-Sherafat S; Azimirad M; Raeisi H; Azizmohammad Looha M; Tavakkoli S; Ahmadi Amoli H; Moghim S; Rostami-Nejad M; Yadegar A; Zali MR
Mol Biol Rep; 2024 Feb; 51(1):265. PubMed ID: 38302841
[TBL] [Abstract][Full Text] [Related]
7. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
8. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
9. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.
Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X
Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
Zhang Q; Zhao H; Wu D; Cao D; Ma W
BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
[TBL] [Abstract][Full Text] [Related]
11. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer and gut microbiota studies in China.
Wang Z; Dan W; Zhang N; Fang J; Yang Y
Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
[TBL] [Abstract][Full Text] [Related]
13. Human Colon Cancer-Derived Clostridioides difficile Strains Drive Colonic Tumorigenesis in Mice.
Drewes JL; Chen J; Markham NO; Knippel RJ; Domingue JC; Tam AJ; Chan JL; Kim L; McMann M; Stevens C; Dejea CM; Tomkovich S; Michel J; White JR; Mohammad F; Campodónico VL; Heiser CN; Wu X; Wu S; Ding H; Simner P; Carroll K; Shrubsole MJ; Anders RA; Walk ST; Jobin C; Wan F; Coffey RJ; Housseau F; Lau KS; Sears CL
Cancer Discov; 2022 Aug; 12(8):1873-1885. PubMed ID: 35678528
[TBL] [Abstract][Full Text] [Related]
14.
Wu J; Zhou B; Pang X; Song X; Gu Y; Xie R; Liu T; Xu X; Wang B; Cao H
Food Funct; 2022 Jul; 13(13):7046-7061. PubMed ID: 35678197
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages.
Li Z; Deng X; Luo J; Lei Y; Jin X; Zhu J; Lv G
Front Oncol; 2021; 11():574318. PubMed ID: 35186705
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
